Tripta Singh
Internal Medicine · Springfield, VANPI 1760874770
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 125 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by Novo Nordisk at 24.6% of the total.
Across 125 payments — averaging $19.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$608
- AbbVie$313
- Amgen$271
- Boehringer Ingelheim$151
- Lilly USA, LLC$129
- Pfizer$128
- plus $872 from 28 others
What the payments were for
- Food & beverage$2,470100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 30 | $608 |
| AbbVie | 16 | $313 |
| Amgen(2 entities) | 15 | $271 |
| Boehringer Ingelheim | 7 | $151 |
| Lilly USA, LLC | 5 | $129 |
| Pfizer | 6 | $128 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $106 |
| AstraZeneca | 6 | $101 |
| Exact Sciences | 2 | $49 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $42 |
| Amarin Pharma, Inc. | 2 | $40 |
| Abbott | 2 | $40 |
| Johnson & Johnson(2 entities) | 2 | $39 |
| Merck | 2 | $37 |
| Astellas Pharma US Inc | 1 | $34 |
| Insightec,inc | 1 | $29 |
| Aerin Medical Inc. | 1 | $29 |
| GSK | 2 | $28 |
| Nestle Healthcare Nutrition Inc. | 1 | $26 |
| Hikma Pharmaceuticals USA | 2 | $25 |
| Eyevance Pharmaceuticals LLC | 2 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Recor Medical Inc | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Seqirus USA Inc | 1 | $18 |
| Bayer | 1 | $17 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Sunovion Pharmaceuticals Inc. | 1 | $14 |
| Boston Scientific | 1 | $13 |
| Bausch Health US, LLC | 1 | $12 |
| Qiagen, LLC | 1 | $12 |
How this compares
$2,470 in reported general payments places this provider in the 85th percentile of 2,724 internal medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $372 |
| Nifedipine ErNifedipine | 20 | $367 |
| Atorvastatin Calcium | 62 | $340 |
| Escitalopram Oxalate | 18 | $276 |
| Rosuvastatin Calcium | 24 | $249 |
| Levothyroxine Sodium | 19 | $201 |
| Losartan Potassium | 18 | $193 |
| Montelukast Sodium | 11 | $137 |
| Gabapentin | 11 | $120 |
| Sertraline Hcl | 11 | $101 |
| Lisinopril | 21 | $89 |
| Carvedilol | 15 | $79 |
| Amlodipine Besylate | 42 | $78 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $70 |
| Azithromycin | 20 | $64 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Springfield
- Kumar AbhishekMechanicsville$1M
- Amit MahajanFalls Church$1M
- Kevin DonohueFalls Church$655K
- Denise BrunerArlington$227K
- Anjali KaloreMidlothian$215K
- Scott GerrishVienna$207K
- Lawrence SchwartzRichmond$205K
- Wally SmithRichmond$177K
- Gautam GulatiMc Lean$136K
- Francesse BatailleDumfries$109K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.